Literature DB >> 20478711

Identification of the three-dimensional pharmacophore of kappa-opioid receptor agonists.

Noriyuki Yamaotsu1, Hideaki Fujii, Hiroshi Nagase, Shuichi Hirono.   

Abstract

A selective kappa-opioid receptor agonist might act as a powerful analgesic without the side effects of mu-opioid receptor-selective drugs such as morphine. The eight classes of known kappa-opioid receptor agonists have different chemical structures, making it difficult to construct a pharmacophore model that takes them all into account. Here we propose a new three-dimensional pharmacophore model that encompasses the kappa-activities of all classes, which utilizes conformational sampling of agonists by high-temperature molecular dynamics and pharmacophore extraction through a series of molecular superpositions. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478711     DOI: 10.1016/j.bmc.2010.04.069

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis and Pharmacology of a Novel κ Opioid Receptor (KOR) Agonist with a 1,3,5-Trioxazatriquinane Skeleton.

Authors:  Shigeto Hirayama; Naohisa Wada; Toru Nemoto; Takashi Iwai; Hideaki Fujii; Hiroshi Nagase
Journal:  ACS Med Chem Lett       Date:  2014-06-26       Impact factor: 4.345

Review 2.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

3.  Determination of structural factors affecting binding to mu, kappa and delta opioid receptors.

Authors:  Svetoslav Slavov; William Mattes; Richard D Beger
Journal:  Arch Toxicol       Date:  2020-02-27       Impact factor: 5.153

4.  Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives.

Authors:  Chiharu Iwamatsu; Daichi Hayakawa; Tomomi Kono; Ayaka Honjo; Saki Ishizaki; Shigeto Hirayama; Hiroaki Gouda; Hideaki Fujii
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.